Targeted in vivo photodynamic therapy with epidermal growth factor receptor-specific peptide linked nanoparticles

International Journal of Pharmaceutics

Volumn 471, Issue 1-2, 2014, Pages 421-429

  Narsireddy, Amreddy ^b   Vijayashree, Kurra ^a   Irudayaraj, Joseph ^c   Manorama, Sunkara V ^b   Rao, Nalam M ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^c Purdue University   (United States)

Author keywords

Affibody; Nanoparticle; Photodynamic therapy; Targeted delivery; Xenograft Animal model

Indexed keywords

CHITOSAN; EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA UROGASTRONE; GOLD NANOPARTICLE; IRON OXIDE; IRON OXIDE NANOPARTICLE; NANOPARTICLE; NITRILOTRIACETATE NICKEL; PHOTOSENSITIZING AGENT; SINGLET OXYGEN; THIOCTIC ACID; UNCLASSIFIED DRUG; 5,10,15,20-TETRA(4-HYDROXYPHENYL)PORPHYRIN; DRUG CARRIER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; GOLD; HYBRID PROTEIN; LIGAND; MAGNETITE NANOPARTICLE; NITRILOTRIACETIC ACID; ORGANOMETALLIC COMPOUND; PEPTIDE; PORPHYRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEATH; CELL VIABILITY ASSAY; CONFOCAL MICROSCOPY; ESCHERICHIA COLI; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; METABOLISM; NUDE MOUSE; PARTICLE SIZE; PHOTOCHEMOTHERAPY; PROCEDURES; RADIATION RESPONSE; SURFACE PROPERTY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CHITOSAN; DRUG CARRIERS; GOLD; LIGANDS; MAGNETITE NANOPARTICLES; MICE, NUDE; NITRILOTRIACETIC ACID; ORGANOMETALLIC COMPOUNDS; PARTICLE SIZE; PEPTIDES; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; SURFACE PROPERTIES; THIOCTIC ACID; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84902335869     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.05.063     Document Type: Article

References (59)

1. R.R. Allison, and C.H. Sibata Oncologic photodynamic therapy photosensitizers: a clinical review Photodiagnosis Photodyn. Ther. 7 2010 61 75
2. S. Anand, B.J. Ortel, S.P. Pereira, T. Hasan, and E.V. Maytin Biomodulatory approaches to photodynamic therapy for solid tumors Cancer Lett. 326 2012 8 16
3. C.L. Arteaga, M.X. Sliwkowski, C.K. Osborne, E.A. Perez, F. Puglisi, and L. Gianni Treatment of HER2-positive breast cancer: current status and future perspectives Nat. Rev. Clin. Oncol. 9 2012 16 32
4. B.M. Barth, I. Altinoglu, S.S. Shanmugavelandy, J.M. Kaiser, D. Crespo-Gonzalez, N.A. DiVittore, C. McGovern, T.M. Goff, N.R. Keasey, J.H. Adair, T.P. Loughran Jr., D.F. Claxton, and M. Kester Targeted indocyanine-green-loaded calcium phosphosilicate nanoparticles for in vivo photodynamic therapy of leukemia ACS Nano 5 2011 5325 5337
5. R. Bonnett, R.D. White, U.J. Winfield, and M.C. Berenbaum Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers Biochem. J. 261 1989 277 280 (Pubitemid 19174790)
6. M. Camerin, M. Magaraggia, M. Soncin, G. Jori, M. Moreno, I. Chambrier, M.J. Cook, and D.A. Russell The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma Eur. J. Cancer 46 2010 1910 1918
7. A. Casas, G. Di Venosa, T. Hasan, and A. Batlle Mechanisms of resistance to photodynamic therapy Curr. Med. Chem. 18 2011 2486 2515
8. J.P. Celli, B.Q. Spring, I. Rizvi, C.L. Evans, K.S. Samkoe, S. Verma, B.W. Pogue, and Hasan,T Imaging and photodynamic therapy: mechanisms, monitoring, and optimization Chem. Rev. 110 2010 2795 2838
9. B. Chen, B.W. Pogue, P.J. Hoopes, and T. Hasan Vascular and cellular targeting for photodynamic therapy Crit. Rev. Eukaryot. Gene Expr. 16 2006 279 305
10. Y. Cheng, C. Samia, J.D. Meyers, I. Panagopoulos, B. Fei, and C. Burda Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer J. Am. Chem. Soc. 130 2008 10643 10647
11. M.C. Derosa, and R.J. Crutchley Photosensitized singlet oxygen and its applications Coord. Chem. Rev. 233 2002 351 371
12. E.C. Dreaden, A.M. Alkilany, X.H. Huang, C.J. Murphy, and M.A. El-Sayed The golden age: gold nanoparticles for biomedicine Chem. Soc. Rev. 41 2012 2740 2779
13. L. Dykman, and N. Khlebtsov Gold nanoparticles in biomedical applications: recent advances and perspectives Chem. Soc. Rev. 41 2012 2256 2282
14. J. Fang, H. Nakamura, and H. Maeda The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect Adv. Drug Deliv. Rev. 63 2011 136 151
15. M. Friedman, A. Orlova, E. Johansson, T.L. Eriksson, I. Hoiden-Guthenberg, V. Tolmachev, F.Y. Nilsson, and S. Stahl Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule J. Mol. Biol. 376 2008 1388 1402
16. M.J. Garland, C.M. Cassidy, D. Woolfson, and R.F. Donnelly Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments Future Med. Chem. 1 2009 667 691
17. B.A. Goff, M. Bamberg, and T. Hasan Photoimmunotherapy of human ovarian carcinoma cells ex vivo Cancer Res. 51 1991 4762 4767
18. B.A. Goff, J. Blake, M.P. Bamberg, and Hasan,T Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model Br. J. Cancer 74 1996 1194 1198 (Pubitemid 26360106)
19. B.A. Goff, U. Hermanto, J. Rumbaugh, J. Blake, M. Bamberg, and Hasan,T Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model Br. J. Cancer 70 1994 474 480 (Pubitemid 24268550)
20. S. Govindarajan, J. Sivakumar, P. Garimidi, N. Rangaraj, J.M. Kumar, N.M. Rao, and V. Gopal Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate Biomaterials 33 2012 2570 2582
21. S.K. Hendren, S.M. Hahn, F.R. Spitz, T.W. Bauer, S.C. Rubin, T. Zhu, E. Glatstein, and D.L. Fraker Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors Ann. Surg. Oncol. 8 2001 65 71 (Pubitemid 32126826)
22. L.R. Howe, and P.H. Brown Targeting the HER/EGFR/ErbB family to prevent breast cancer Cancer Prev. Res. (Phila.) 4 2011 1149 1157
23. Z. Huang A review of progress in clinical photodynamic therapy Technol. Cancer Res. Treat 4 2005 283 293 (Pubitemid 40807688)
24. J.A. Incorvati, S. Shah, Mu,Y, and J. Lu Targeted therapy for HER2 positive breast cancer J. Hematol. Oncol. 2013 6
25. R.K. Jain Antiangiogenic therapy for cancer current and emerging concepts Oncology (Williston Park) 19 2005 7 16
26. L. Jardines, M. Weiss, B. Fowble, and M. Greene Neu(c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancer Pathobiology 61 1993 268 282
27. A. Khdair, D. Chen, Y. Patil, L. Ma, Q.P. Dou, M.P. Shekhar, and J. Panyam Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance J. Control. Release 141 2010 137 144
28. Y.N. Konan, R. Cerny, J. Favet, M. Berton, R. Gurny, and E. Allemann Preparation and characterization of sterile sub-200 nm meso-tetra(4- hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy Eur. J. Pharm. Biopharm. 55 2003 115 124 (Pubitemid 36120503)
29. T. Lammers, S. Aime, W.E. Hennink, G. Storm, and F. Kiessling Theranostic nanomedicine Acc. Chem. Res. 44 2011 1029 1038
30. S. Laurent, D. Forge, M. Port, A. Roch, C. Robic, E.L. Vander, and R.N. Muller Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications Chem. Rev. 108 2008 2064 2110
31. M. Lewin, N. Carlesso, C.H. Tung, X.W. Tang, D. Cory, D.T. Scadden, and R. Weissleder Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells Nat. Biotechnol. 18 2000 410 414 (Pubitemid 30217528)
32. F.J. Liu, S. Laurent, H. Fattahi, L.V. Elst, and R.N. Muller Superparamagnetic nanosystems based on iron oxide nanoparticles for biomedical imaging Nanomedicine 6 2011 519 528
33. J. Lofblom, J. Feldwisch, V. Tolmachev, J. Carlsson, S. Stahl, and F.Y. Frejd Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications FEBS Lett. 584 2010 2670 2680
34. C. Morris The role of EGFR-directed therapy in the treatment of breast cancer Breast Cancer Res. Treat. 75 2002 S51 S55
35. K. Nawalany, B. Kozik, M. Kepczynski, S. Zapotoczny, M. Kumorek, M. Nowakowska, and B. Jachimska Properties of polyethylene glycol supported tetraarylporphyrin in aqueous solution and its interaction with liposomal membranes J. Phys. Chem. B 112 2008 12231 12239
36. F.Y. Nilsson, and V. Tolmachev Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy Curr. Opin. Drug Discov. Devel. 10 2007 167 175 (Pubitemid 46438646)
37. N. Nishiyama, H.R. Stapert, G.D. Zhang, D. Takasu, D.L. Jiang, T. Nagano, T. Aida, and K. Kataoka Light-harvesting ionic dendrimer porphyrins as new photosensitizers for photodynamic therapy Bioconjug. Chem. 14 2003 58 66 (Pubitemid 36169017)
38. A. Orlova, J. Feldwisch, L. Abrahmsen, and V. Tolmachev Update: affibody molecules for molecular imaging and therapy for cancer Cancer Biother. Radiopharm. 22 2007 573 584 (Pubitemid 350058993)
39. T.C. Pagonis, J. Chen, C.R. Fontana, H. Devalapally, K. Ruggiero, X. Song, F. Foschi, J. Dunham, Z. Skobe, H. Yamazaki, R. Kent, A.C. Tanner, M.M. Amiji, and N.S. Soukos Nanoparticle-based endodontic antimicrobial photodynamic therapy J. Endod. 36 2010 322 328
40. E. Reddi, G. Jori, and F.F. Rubaltelli Photochemical and photosensitizing properties of monomeric and dimeric Sn(IV)-protoporphyrin J. Photochem. Photobiol. B 8 1991 159 167
41. 4-Au nanoparticles for biomedical applications Chempluschem 77 2012 284 292
42. A. Roby, S. Erdogan, and P. Torchilin,V Enhanced in vivo antitumor efficacy of poorly soluble PDT agent, meso-tetraphenylporphine, in PEG-PE-based tumor-targeted immunomicelles Cancer Biol. Ther. 6 2007 1136 1142 (Pubitemid 351574968)
43. E.S. Shibu, M. Hamada, N. Murase, and Biju,V Nanomaterials formulations for photothermal and photodynamic therapy of cancer J. Photochem. Photobiol. C -Photochem. Rev. 15 2013 53 72
44. K. Song, B. Kong, L. Li, Q. Yang, Y. Wei, and X. Qu Intraperitoneal photodynamic therapy for an ovarian cancer ascite model in Fischer 344 rat using hematoporphyrin monomethyl ether Cancer Sci. 98 2007 1959 1964 (Pubitemid 350002203)
45. T. Stuchinskaya, M. Moreno, M.J. Cook, D.R. Edwards, and D.A. Russell Targeted photodynamic therapy of breast cancer cells using antibody- phthalocyanine-gold nanoparticle conjugates Photochem. Photobiol. Sci. 10 2011 822 831
46. A.B. Thompson, A.K. Calhoun, B.J. Smagghe, M.D. Stevens, M.T. Wotkowicz, M. Hatziioannou,V, and C. Bamdad A gold nanoparticle platform for protein-protein interactions and drug discovery ACS Appl. Mater. Interfaces 3 2011 2979 2987
47. V. Tolmachev, A. Orlova, F.Y. Nilsson, J. Feldwisch, A. Wennborg, and L. Abrahmsen Affibody molecules: potential for in vivo imaging of molecular targets for cancer therapy Expert. Opin Biol. Ther. 7 2007 555 568 (Pubitemid 46524679)
48. M. Triesscheijn, P. Baas, J.H. Schellens, and F.A. Stewart Photodynamic therapy in oncology Oncologist 11 2006 1034 1044 (Pubitemid 44564813)
49. Y. Vakrat-Haglili, L. Weiner, V. Brumfeld, A. Brandis, Salomon,Y, B. McLlroy, B.C. Wilson, A. Pawlak, M. Rozanowska, T. Sarna, and A. Scherz The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide J. Am. Chem. Soc. 127 2005 6487 6497 (Pubitemid 40627771)
50. S. Verma, G.M. Watt, Z. Mal, and Hasan,T Strategies for enhanced photodynamic therapy effects Photochem. Photobiol. 83 2007 996 1005 (Pubitemid 47438530)
51. V. Wagner, A. Dullaart, A.K. Bock, and A. Zweck The emerging nanomedicine landscape Nat. Biotechnol. 24 2006 1211 1217 (Pubitemid 44564760)
52. L.Y. Wang, X.Y. Shi, C.S. Yang, and D.M. Huang Versatile RBC-derived vesicles as nanoparticle vector of photosensitizers for photodynamic therapy Nanoscale 5 2013 416 421
53. W. Wang, D.I. Wang, and Z. Li Facile fabrication of recyclable and active nanobiocatalyst: purification and immobilization of enzyme in one pot with Ni-NTA functionalized magnetic nanoparticle Chem. Commun. (Camb.) 47 2011 8115 8117
54. M.E. Wieder, D.C. Hone, M.J. Cook, M.M. Handsley, J. Gavrilovic, and D.A. Russell Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a 'Trojan horse' Photochem. Photobiol. Sci. 5 2006 727 734 (Pubitemid 44186866)
55. M. Wozniak, F. Tanfani, E. Bertoli, G. Zolese, and J. Antosiewicz A new fluorescence method to detect singlet oxygen inside phospholipid model membranes Biochim. Biophys. Acta 1082 1991 94 100
56. C.J. Xu, and S.H. Sun New forms of superparamagnetic nanoparticles for biomedical applications Adv. Drug Deliv. Rev. 65 2013 732 743
57. F. Yan, and R. Kopelman The embedding of meta-tetra(hydroxyphenyl)- chlorin into silica nanoparticle platforms for photodynamic therapy and their singlet oxygen production and pH-dependent optical properties Photochem. Photobiol. 78 2003 587 591
58. G.D. Zhang, A. Harada, N. Nishiyama, D.L. Jiang, H. Koyama, T. Aida, and K. Kataoka Polyion complex micelles entrapping cationic dendrimer porphyrin: effective photosensitizer for photodynamic therapy of cancer J Control. Release 93 2003 141 150 (Pubitemid 37421356)
59. A. Zhou, Y. Wei, B. Wu, Q. Chen, and D. Xing Pyropheophorbide A and c(RGDyK) comodified chitosan-wrapped upconversion nanoparticle for targeted near-infrared photodynamic therapy Mol. Pharm. 9 2012 1580 1589